VANNUCCHI, GUIA MARIA
VANNUCCHI, GUIA MARIA
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
2022 I. Campi, G. Vannucchi, I. Muller, E. Lazzaroni, N. Currò, M. Dainese, B. Montacchini, D. Covelli, C. Guastella, L. Pignataro, L. Fugazzola, M. Arosio, M. Salvi
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy
2021 G. Vannucchi, I. Campi, D. Covelli, N. Curro, E. Lazzaroni, A. Palomba, D. Soranna, A. Zambon, L. Fugazzola, I. Muller, C. Guastella, M. Salvi
The thyroid risk score (TRS) for nodules with indeterminate cytology
2021 C. Colombo, M. Muzza, G. Pogliaghi, S. Palazzo, G. Vannucchi, L. Vicentini, L. Persani, G. Gazzano, L. Fugazzola
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy.
2020 G. Lanzolla, G. Vannucchi, I. Ionni, I. Campi, F. Sileo, E. Lazzaroni, M. Marinò
Prevention of orbitopathy by oral or intravenous steroid prophylaxis in short duration Graves’ disease patients undergoing radioiodine ablation : A prospective randomized control trial study
2019 G. Vannucchi, D. Covelli, I. Campi, N. Curro, D. Dazzi, M. Rodari, G. Pepe, A. Chiti, C. Guastella, E. Lazzaroni, M. Salvi
Primary Adrenal Insufficiency during Lenvatinib or Vandetanib and Improvement of Fatigue after Cortisone Acetate Therapy
2018 C. Colombo, S. De Leo, M. Di Stefano, G. Vannucchi, L. Persani, L. Fugazzola
Thyroid volume and serum calcitonin changes during pregnancy
2017 G. Vannucchi, D. Covelli, B. Vigo, M. Perrino, L. Mondina, L. Fugazzola
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
2016 V. De Stefano, A.M. Vannucchi, M. Ruggeri, F. Cervantes, A. Alvarez-Larrán, A. Iurlo, M.L. Randi, L. Pieri, E. Rossi, P. Guglielmelli, S. Betti, E. Elli, M.C. Finazzi, G. Finazzi, E. Zetterberg, N. Vianelli, G. Gaidano, I. Nichele, D. Cattaneo, M. Palova, M.H. Ellis, E. Cacciola, A. Tieghi, J.C. Hernandez-Boluda, E. Pungolino, G. Specchia, D. Rapezzi, A. Forcina, C. Musolino, A. Carobbio, M. Griesshammer, T. Barbui
Therapy of endocrine disease : Endocrine dilemma : management of Graves' orbitopathy
2016 I. Campi, G. Vannucchi, M. Salvi
The long-term impact of controlled ovarian hyperstimulation on thyroid function
2016 A. Busnelli, E. Somigliana, S. Ferrari, F. Filippi, G. Vannucchi, L. Fugazzola, L. Fedele
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy
2015 D. Covelli, G. Vannucchi, I. Campi, N. Currò, R. D'Ambrosio, M. Maggioni, U. Gianelli, P. Beck-Peccoz, M. Salvi
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe graves' orbitopathy : a randomized controlled study
2015 M. Salvi, G. Vannucchi, N. Currò, I. Campi, D. Covelli, D. Dazzi, S. Simonetta, C. Guastella, L. Pignataro, S. Avignone, P. Beck-Peccoz
B cell activating factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases
2015 I. Campi, D. Tosi, S. Rossi, G. Vannucchi, D. Covelli, F. Colombo, E. Trombetta, L. Porretti, L. Vicentini, G. Cantoni, N. Currò, P. Beck-Peccoz, G. Bulfamante, M. Salvi
Impact of estrogen and progesterone receptors expression on the clinical and molecular features of papillary thyroid cancer
2015 G. Vannucchi, S. De Leo, M. Perrino, S. Rossi, D. Tosi, V. Cirello, C. Colombo, G. Bulfamante, L. Vicentini, L. Fugazzola
Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization
2014 L. Benaglia, A. Busnelli, E. Somigliana, M. Leonardi, G. Vannucchi, S. De Leo, L. Fugazzola, G. Ragni, L. Fedele
Feasibility study for the introduction of a new treatment method for benign thyroid nodules in a teaching and research hospital
2014 M. Longo, P. Cassoli, L. Fugazzola, G. Vannucchi,M. Lanzoni, S. Castaldi
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy
2014 N. Curro, D. Covelli, G. Vannucchi, I. Campi, G. Pirola, S. Simonetta, D. Dazzi, C. Guastella, L. Pignataro, P. Beck-Peccoz, R. Ratiglia, M. Salvi
Cardiovascular events and intensity of treatment in polycythemia vera
2013 R. Marchioli, G. Finazzi, G. Specchia, R. Cacciola, R. Cavazzina, D. Cilloni, V. De Stefano, E. Elli, A. Iurlo, R. Latagliata, F. Lunghi, M. Lunghi, R.M. Marfisi, P. Musto, A. Masciulli, C. Musolino, N. Cascavilla, G. Quarta, M.L. Randi, D. Rapezzi, M. Ruggeri, E. Rumi, A.R. Scortechini, S. Santini, M. Scarano, S. Siragusa, A. Spadea, A. Tieghi, E. Angelucci, G. Visani, A.M. Vannucchi, T. Barbui
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy.
2013 I. Campi, G. Vannucchi, A. Minetti, D. Dazzi, S. Avignone, D. Covelli, N. Currò, R. Ratiglia, C. Guastella, L. Pignataro, P. Beck-Peccoz, M. Salvi
Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy
2012 G. Vannucchi, D. Covelli, N. Currò, D. Dazzi, A. Maffini, I. Campi, P. Bonara, C. Guastella, L. Pignataro, R. Ratiglia, P. Beck Peccoz, M. Salvi